DANIELLE GIBBONS: Open Payments
NPI 1194737593 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,431 in 222 payments from 20 companies in 2025. Trend: 2023 $3,107 · 2024 $7,690 · 2025 $15,431
Speaker / faculty: $10,481Food & beverage: $4,728Travel & lodging: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 42 | $11,675 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 33 | $808 |
| Otsuka America Pharmaceutical, Inc. | 40 | $734 |
| E.R. Squibb & Sons, L.L.C. | 17 | $404 |
| Janssen Pharmaceuticals, Inc | 13 | $335 |
| ABBVIE INC. | 20 | $298 |
| Alkermes, Inc. | 13 | $207 |
| Neurocrine BioSciences, Inc. | 11 | $199 |
| Axsome Therapeutics, Inc. | 7 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $94 |
Products named: UZEDY, CAPLYTA, REXULTI, COBENFY, ABILIFY MAINTENA, VRAYLAR, INVEGA SUSTENNA, INGREZZA.
Industry payments across PA — which companies pay providers there.
